Kelly L Stauch1, Phillip R Purnell, Howard S Fox. 1. Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center , 985800 Nebraska Medical Center, Omaha, Nebraska 68198, United States.
Abstract
Synaptic mitochondria are essential for maintaining calcium homeostasis and producing ATP, processes vital for neuronal integrity and synaptic transmission. Synaptic mitochondria exhibit increased oxidative damage during aging and are more vulnerable to calcium insult than nonsynaptic mitochondria. Why synaptic mitochondria are specifically more susceptible to cumulative damage remains to be determined. In this study, the generation of a super-SILAC mix that served as an appropriate internal standard for mouse brain mitochondria mass spectrometry based analysis allowed for the quantification of the proteomic differences between synaptic and nonsynaptic mitochondria isolated from 10-month-old mice. We identified a total of 2260 common proteins between synaptic and nonsynaptic mitochondria of which 1629 were annotated as mitochondrial. Quantitative proteomic analysis of the proteins common between synaptic and nonsynaptic mitochondria revealed significant differential expression of 522 proteins involved in several pathways including oxidative phosphorylation, mitochondrial fission/fusion, calcium transport, and mitochondrial DNA replication and maintenance. In comparison to nonsynaptic mitochondria, synaptic mitochondria exhibited increased age-associated mitochondrial DNA deletions and decreased bioenergetic function. These findings provide insights into synaptic mitochondrial susceptibility to damage.
Synaptic mitochondria are essential for maintaining calcium homeostasis and producing ATP, processes vital for neuronal integrity and synaptic transmission. Synaptic mitochondria exhibit increased oxidative damage during aging and are more vulnerable to calcium insult than nonsynaptic mitochondria. Why synaptic mitochondria are specifically more susceptible to cumulative damage remains to be determined. In this study, the generation of a super-SILAC mix that served as an appropriate internal standard for mouse brain mitochondria mass spectrometry based analysis allowed for the quantification of the proteomic differences between synaptic and nonsynaptic mitochondria isolated from 10-month-old mice. We identified a total of 2260 common proteins between synaptic and nonsynaptic mitochondria of which 1629 were annotated as mitochondrial. Quantitative proteomic analysis of the proteins common between synaptic and nonsynaptic mitochondria revealed significant differential expression of 522 proteins involved in several pathways including oxidative phosphorylation, mitochondrial fission/fusion, calcium transport, and mitochondrial DNA replication and maintenance. In comparison to nonsynaptic mitochondria, synaptic mitochondria exhibited increased age-associated mitochondrial DNA deletions and decreased bioenergetic function. These findings provide insights into synaptic mitochondrial susceptibility to damage.
Mitochondria are energy-generating
organelles that, in addition
to producing ATP, play a vital role in the maintenance of intracellular
calcium homeostasis and induction of apoptosis. Mitochondria are quite
dynamic; they fuse, divide, and are transported within eukaryotic
cells in response to various physiological cues. Increasing evidence
suggests mitochondria in different cell types and different cellular
compartments can exhibit heterogeneity in their function, trafficking
patterns, lifespan, and morphology.[1,2] Mitochondrial
heterogeneity as observed in neurons may facilitate unique requirements
of the different cellular compartments. Neurons are polarized cells
that consist of three distinct structural and functional domains:
the cell body (soma), an axon, and complex dendrites with many branches
and elaborate arbors. The formation of an axon–dendrite synaptic
connection allows for interneuronal communication. Synaptic mitochondria
are defined as those docked and aggregated in synapses which are sites
of high-energy demand and extensive calcium fluctuations.[3,4] Thus, neuronal function and synaptic transmission rely largely on
mitochondrial accumulation in synapses for energy production and maintenance
of calcium levels.[5−7] Mitochondrial dysfunction and defects in mitochondrial
fission and fusion are predicted to affect various aspects of neuronal
physiology.[8,9] The occurrence of neurological defects associated
with a great variety of diseases caused by mutations in genes encoding
mitochondrial proteins further emphasizes the importance of neuronal
mitochondria function.[9]Mitochondrial
biogenesis depends on nuclear encoded genes, and
degradation machineries are primarily located in the perinuclear region
of neuronal cytoplasm.[4,10] Therefore, synaptic mitochondria
must be transported back and forth between the soma and synapses via
mitochondrial transport systems. Mitochondrial fission/fusion cycles
facilitate trafficking to and from the synapse, in addition to preserving
the health of mitochondrial networks by facilitating degradation of
the most damaged mitochondria.[6,11] The proper degradation
of aged and damaged mitochondria through autophagy (termed mitophagy)
is essential for neuronal survival and function. Synaptic mitochondria
display a longer lifespan and increased vulnerability to cumulative
damage than nonsynaptic mitochondria.[12] Synaptic mitochondria display increased oxidative damage during
aging and are particularly susceptible to calcium insult.[12−14] Several hypotheses have been proposed to account for the increased
vulnerability of synaptic mitochondria including relative isolation
in comparison to clusters of mitochondria found in the neuronal soma,
increased exposure to oxidative stress and calcium fluxes, older age,
and high energy demands.[12,15−17] However, unraveling the link between the cause of synaptic mitochondrial
vulnerability and the resulting cumulative damage has proven a complex
task, particularly since mitochondria are dynamic organelles with
interdependent functions. In the present work, we used quantitative
mass spectrometry (MS) based analysis to examine the proteome differences
between synaptic and nonsynaptic mitochondria in order to illuminate
pathways that are necessary for important heterogeneous functions
and contribute to the increased vulnerability of synaptic mitochondria.Stable isotope labeling with amino acids in cell culture (SILAC),
where cells are differentially labeled by growing them in “light”
medium (normal amino acids) or “heavy” medium (containing
stable isotope analogues that are substituted for certain amino acids)
is an ideal method for accurate quantitative proteomics. The use of
SILAC has recently been expanded to tissue analysis by using a mix
of multiple SILAC-labeled cell lines as internal standards for tissue
proteome quantification (termed super-SILAC).[18−20] Since our goal
is to characterize alterations in the synaptic mitochondrial proteome,
we first generated a super-SILAC mix and performed label-free proteomic
analysis to validate its use as an appropriate internal standard for
mouse brain mitochondria. The use of shotgun proteomics combined with
the super-SILAC quantitative approach allowed for the identification
of, in total, 2260 proteins common between synaptic and nonsynaptic
mitochondria of which 1629 were annotated to be mitochondrial and
522 were found to be significantly differentially expressed. Potential
proteomic differences responsible for the susceptibility of synaptic
mitochondria to cumulative damage were identified. Orthogonal validation
using Western blotting and the combination of Gene Ontology categories
enrichment analysis and Ingenuity Pathway Analyses identified key
processes and proteins important for neuronal function that are altered
in synaptic mitochondria. Functionally, bioenergetic analysis revealed
decreased respiration in synaptic mitochondria, which also exhibited
an increased presence of mitochondrial DNA (mtDNA) deletions.
Experimental
Procedures
Animals
A total of 11 C57BL/6 male mice (substrain
C57BL/6NCrl, 10 months old) were obtained from Charles River Laboratories
International, Inc. Two were used for MS, six were used for Seahorse
XF24 bioenergetic analysis, and the remaining three were used for
electron microscopy and mtDNA mutation analyses. All protocols were
implemented in accordance with NIH guidelines and approved by the
Institutional Animal Care and Use Committee at the College of Medicine,
University of Nebraska Medical Center. Animals were housed with a
constant 12 h light/dark cycle in a controlled room and fed standard
pellet mouse diet and water ad libitum.
Isolation of Synaptic and
Nonsynaptic Brain Mitochondria
Synaptic and nonsynaptic mitochondria
were isolated from 10-month-old
C57BL/6 mice using a method modified from that described previously.[21] Following decapitation, brains were quickly
removed and placed in ice-cold isolation medium (IM) containing 225
mM sucrose, 75 mM mannitol, 1 mM EGTA, 5 mM Hepes, and cOmplete Mini,
EDTA-free protease inhibitor cocktail (Roche Diagnostics) adjusted
to pH 7.4 with Tris-base. All homogenization and centrifugation steps
were carried out on ice and at 4 °C, respectively. Brains were
chopped into small pieces and homogenized with 35 strokes in a Dounce
homogenizer. The homogenate was centrifuged at 1300g for 3 min, and then the supernatant was collected. The resulting
pellet was resuspended in IM and centrifuged again at 1300g for 3 min. The pooled supernatants were centrifuged at
21000g for 10 min. This pellet was then resuspended
in 15% Percoll and layered on top of a 24% and 40% Percoll gradient
(prepared from 100% Percoll solution containing 225 mM sucrose, 75
mM mannitol, 1 mM EGTA, and 5 mM Hepes adjusted to pH 7.4 with HCl).
After centrifugation for 8 min at 30700g the banding
near the interface of the upper two layers of the gradient, which
contains mainly synaptosomes, was collected and diluted in IM. The
material accumulating at the interface between the 40% and the 24%
Percoll solution, which is enriched with nonsynaptic mitochondria
was also collected and diluted in IM.The synaptosomal fraction
was transferred to a nitrogen cavitation vessel (Parr Instrument Co.)
where the pressure was equilibrated to 900 psi for 15 min followed
by depressurization to ATM pressure releasing the synaptic mitochondria.[21] This suspension was then added to the top of
24% Percoll and centrifuged for 10 min at 30700g.
The pellet containing the synaptic mitochondria was resuspended in
IM. The resuspended synaptic and nonsynaptic mitochondria were centrifuged
at 16700g for 10 min. Finally, the pellets were resuspended
in IM with fatty acid free BSA followed by centrifugation at 6900g for 10 min. These final pellets, which contain synaptic
or nonsynaptic mitochondria, were both further purified using an anti-TOM22
immunomagnetic affinity isolation (Miltenyi Biotech). Resulting mitochondria
were lysed in 100 mM Tris-HCl with 4% (w/v) SDS and 0.1 M DTT adjusted
to pH 7.6. Lysates were incubated at 95 °C for 5 min and then
briefly sonicated. Protein concentrations were determined using a
Pierce 660 nm Protein Assay (Thermo Scientific).
Identification
of Mitochondria with Electron Microscopy
Isolated synaptic
and nonsynaptic mitochondria were fixed overnight
in 2.5% glutaraldehyde in 0.1 M cacodylate buffer, pH 7.4 at 4 °C,
postfixed with 1% cacodylate-buffered osmium tetraoxide for 2 h at
room temperature, and then dehydrated in a graded series of ethanol,
briefly transferred to propylene oxide, and embedded in Epon-Araldite.
Routine thin-section ultrastructural analysis was performed as described
previously.[22] Sections were stained with
uranyl acetate and lead citrate, and then randomly selected noncontiguous,
nonoverlapping, digitized images of each mitochondrial pellet (21000
and 52000× magnification) were captured on a FEI Tecnai G2 Spirit
transmission electron microscope. Mitochondria were classified as
intact by visualization of condensed cristae and an uninterrupted
outer membrane.
Cell Culture and Mitochondrial Super-SILAC
Mix Preparation
The mouse cell lines Neuro-2a, CATH.a, NB41A3,
and C8-D1A were
obtained from ATCC. The cells were grown in DMEM/F-12 media supplemented
with fetal bovine serum, l-glutamine, and penicillin–streptomycin.
At 80% confluency, cells were rinsed twice with PBS, collected, pelleted,
and flash frozen in liquid nitrogen followed by storage at −80
°C. Mitochondria were isolated from lysed cells by sequential
differential centrifugation using the Mitochondrial Isolation Kit
for Cultured Cells (Mitosciences) followed by anti-TOM22 immunomagnetic
isolation (Miltenyi Biotech). For stable-isotope labeling by amino
acids in cell culture (SILAC) experiments, the four cell lines were
SILAC-labeled by culturing in Advanced DMEM/F-12 (Invitrogen) in which
the natural lysine and arginine were replaced by heavy isotope-labeled
amino acids, (U-13C615N4)-l-arginine (Arg-10) and (U-13C6)-l-lysine (Lys-6) supplemented with 10% dialyzed fetal bovine
serum, SILAC glucose solution, l-glutamine, SILAC phenol
red solution, and penicillin–streptomycin. Cells were cultured
for at least seven generations in the SILAC media until fully labeled
as assessed by quantitative MS. The mitochondrial super-SILAC mix
was prepared by mixing equal amounts of each of the four cell lines
of heavy mitochondrial lysate which were then combined with unlabeled
lysate from either the synaptic or nonsynaptic mitochondria isolated
from mouse brain as described above.
Protein Digestion and Fractionation
The filter-aided
proteome preparation technique[23] with a
20-μm filter (Pall Corporation) was used for protein trypsinization.
The resultant peptides were cleaned with an Oasis mixed-mode weak
cation-exchange cartridge (Waters). Peptides were quantified using
a NanoDrop 2000 UV–vis Spectrophotometer (Thermo Scientific)
in conjunction with the Scopes method for protein quantification.[24] Isoelectric focusing was performed using an
Agilent 3100 OFFGEL Fractionator with the pH 3–10 low-resolution
kit (Agilent Technologies). Fractions were prepared for MS with Pierce
C-18 PepClean Spin Columns (Thermo Fisher) in accord with manufacturer’s
instructions. Samples were dried with a Savant ISS 110 SpeedVac Concentrator
(Thermo Fisher) and resuspended in 6 μL of 0.1% formic acid
for LC–MS/MS analysis. Two independent biological replicates
were performed for each synaptic and nonsynaptic preparation.
LC–MS/MS
and Data Analysis
MS was conducted
using an Eksigent ultra nano-HPLC with a cHiPLC system connected to
an AB Sciex TripleTOF (TTOF) mass spectrometer equipped with a nanospray
configuration (AB Sciex). Samples were loaded onto a 200 μm
× 6 mm ChromXPC18-CL 3 μm 120 Å trap column (Eksigent),
washed with 98:2 LC-MS water with 1% formic acid for 10 min, and then
eluted through a 200 μm × 15 cm ChromXPC18-CL 3 μm
120 Å analytical column (Eksigent) at 300 nL/min with a linear
gradient of acetonitrile from 0 to 60% over the course of 90 min.
β-Galactosidase standards (25 fmol) were used for calibration.
Peptide and protein lists were generated by analyzing TTOF data obtained
with Protein Pilot version 4.5 (Paragon Algorithm: 4.5.0.0, 1654)
software. Using the paragon method,[25] the
peak lists were compared against the Uniprot 2013_07 release of 26-June-2013
of UniProtKB/Swiss-Prot containing 540546 sequence entries with contaminants
added. The search parameters were set as a maximum of two missed cleavages,
carbamidomethyl (C) as fixed modification, N-acetyl
(protein) and oxidation (M) as variable modifications, top 6 MS/MS
peaks per 100 Da, and MS/MS mass tolerance of 0.5 Da. The Protein
Pilot search effort was set to “Thorough ID” and the
False Discovery Rate Analysis was engaged, with the default setting
for ‘Detected Protein Threshold (Unused ProtScore (Conf))’
at >0.05 (10.0%). Exclusion criteria to remove proteins from analysis
were as follows: FDR of 0.05 for both peptides and proteins, peptides
must contain at least 6 amino acids, contaminants as identified through
the database search and proteins identified as being in the reverse
database. The additional cutoff values of Unused ProtScore ≥1.3
and number of unique peptides ≥2 were applied to the data.
Quantification was performed using the heavy super-SILAC mix as an
internal standard and ratios were normalized to this mix and expressed
here as light-to-heavy (L/H, sample/super-SILAC internal standards).
To select proteins that show differential expression, our data was
uploaded to the Cyber-T Web server (http://cybert.ics.uci.edu/),[26] which implements a t test using a Bayesian regularization method for quantitative MS
analysis and multiple tests corrections were employed to derive the
Posterior Probabilities of Differential Expression (PPDE) and perform
Benjamini and Hochberg (BH) corrections. Cutoffs for proteins deemed
as significantly differentially expressed were p values
≤0.05, PPDE values ≥0.95, and BH corrected q values (FDR) ≤ 0.05.The synaptic and nonsynaptic mitochondria
were compared as follows. First, protein ratios were determined against
the super-SILAC internal standard for each of the mitochondrial samples
(synaptic and nonsynaptic), which are expressed as L/H. Then, we determined
the “ratio of ratio” value, which is the change in protein
expression between the synaptic and nonsynaptic mitochondria. The
heat maps represent the changes in protein expression levels in synaptic
mitochondria relative to nonsynaptic mitochondria. The protein expression
changes were imported into a multiple experiment viewer (Dana-Faber
Cancer Institute). The heat maps were generated by this program and
the color scale was set to encompass all values. All statistical analysis
and linear fits were completed using Excel (Microsoft) and Prism (GraphPad
Software).
Bioinformatic Analysis
Hierarchical
clustering and
principal component analyses of proteins were performed using Partek
Genomics Suite 6.6 version 6.12.0713 software. MitoMiner v3.1–2013_10
(MRC: Mitochondrial Biology Unit; mitominer.mrc-mbu.cam.ac.uk) was used to annotate our identified and quantified proteins as
mitochondrial. Categorical annotation was supplied in the form of
Gene Ontology (GO) biological process, molecular function, and cellular
component as defined by the Database for the Annotation, Visualization,
and Integrated Discovery (DAVID; http://david.abcc.ncifcrf.gov/).[27] The DAVID EASE score is calculated
using one-tail Fisher Exact probability values for gene-enrichment
analysis. The Ingenuity Pathway Analysis (IPA; Ingenuity Systems; http://www.ingenuity.com) Upstream Regulator and Downstream
Effects Analysis tool was used to predict alterations in the activity
of mitochondrial transcriptional regulators based on our uploaded
protein expression data.
Immunoblotting
Equal amounts of
mitochondrial lysates
prepared as described above (15 μg) were loaded onto 4–12%
Bis-Tris gels, transferred to nitrocellulose membranes, blocked, and
incubated with the following antibodies overnight at 4 °C: the
oxidative phosphorylation (OXPHOS) panel (1:5000) (MS604; Mitoscences),
VDAC1 (1:10,000) (4661; Cell Signaling), GAPDH (1:10,000) (437000;
Invitrogen), ATP5H (1:10,000) (MS504; Mitosciences), MCU (1:1,000)
(HPA016480; Sigma-Aldrich), MFN1 (1:2,000) (ab57602; Abcam), TFAM
(1:4,000) (LS-C30495; LifeSpan Biosciences), and Synaptophysin (1:1,000)
(4329; Cell Signaling). The OXPHOS antibody panel is a mix of antibodies
that include NDUFB8, SDHB, UQCRC2, COXI, and ATP5A1. The expression
of mitochondrial proteins (VDAC1 and GAPDH) commonly used as loading
controls have been shown to exhibit expression changes in response
to different conditions[28,29] and in our proteomics;
therefore, we performed Coomassie staining to confirm equal protein
loading (Figure S1, Supporting Information). As revealed by our proteomics, VDAC1 expression is significantly
decreased in synaptic mitochondria (log2 = −0.42, p = 0.015, PPDE = 0.96, BH = 0.039); however, VDAC1 immunoblotting
was included to show consistent loading between all Western blots
despite expression changes. Confirmation of equal protein loading
for each membrane was performed by Ponceau staining. Chemiluminescent
bands were visualized with an Image Station 4000MM Pro and analyzed
using Carestream Molecular Imaging software (both from Carestream
Health, Inc.).
Isolation and Bioenergetic Analysis of Isolated
Brain Mitochondria
Synaptic and nonsynaptic mitochondria
were isolated from 10-month-old
mice as described above with the following modifications. The mouse
brains were homogenized in mitochondrial isolation buffer (MSHE+BSA):
70 mM sucrose, 210 mM mannitol, 5 mM HEPES, 1 mM EGTA and 0.5% (w/v)
fatty acid free BSA (pH 7.2) using only 10 strokes in a Dounce homogenizer.
Following the Percoll centrifugation, the final centrifugation steps
were performed at 8000g for 10 min. The anti-TOM22
immunomagnetic affinity isolation purification step was not performed.
Final pellets for bioenergetic analysis were resuspended in a minimal
volume of MSHE + BSA. Total mitochondrial concentrations were determined
using the BCA method. Isolated mitochondria were used immediately
for analysis.The Seahorse XF24 Flux Analyzer (Seahorse) was
equilibrated to 37 °C overnight, and a modified protocol was
used based on previous work in mouse liver mitochondria.[30] The isolated synaptic and nonsynaptic mitochondria
(10 μg) were plated in V7-PS XF24 cell culture microplates in
a volume of 50 μL mitochondrial assay solution (MAS) containing
10 mM pyruvate, 2 mM malate, and 4 μM FCCP as substrate for
the electron flow experiment. After centrifugation for 15 min at 2000g to attach mitochondria, 450 μL of MAS (containing
substrate) was added to each well, and the plate was incubated at
37 °C for 8 min to equilibrate temperature. The final concentrations
of additions to the wells were 2 μM rotenone, 10 mM succinate,
4 μM antimycin A, and 10 mM ascorbate with 100 μM TMPD
for the electron flow assay. The electron flow assay was run in 3–4
technical replicate wells for each independent biological replicate
(n = 6). XF24 data was calculated using the algorithm
previously described and used by the Seahorse software package.[31] Statistical analysis conducted in PRISM (GraphPad
Software) using one-way ANOVA and post-test with Tukey’s multiple
comparison test.
PCR mtDNA Deletion Assay
To anneal
DNA segments flanking
three-direct repeats in the regions 8884–13357 oligonucleotide
primers were synthesized (Eurofins MWG Operon).[32] For this, mtDNA was prepared from the synaptic and nonsynaptic
mitochondrial fractions using the QIAamp DNA Micro Kit (Qiagen); the
oligonucleotide outer primers, 5′-TAATTCAAGCCTACGTATTC-3′
(forward) and 5′-GGGATGTTTTTAGGCTTAGG-3′ (reverse),
and oligonucleotide nested primers, 5′-CAAGTCCATGACCATTAACTGG-3′
(forward) and 5′-GATTTTATGGGTGTAATGCG-3′ (reverse),
were used for the mtDNA deletion PCR reaction. The mtDNA segment (471–670)
encoding 12S rRNA was also amplified as undeleted mtDNA controls in
each sample, using 5′-GACAGCTAAGACCCAAACTG-3′ (forward)
and 5′-TTAGCAAGAGATGGTGAGGT-3′ (reverse) primers. PCR
conditions were initial denaturation at 94 °C for 4 min, followed
by 30 cycles of denaturation, annealing, and extension at 94 °C
for 20 s, 55 °C for 20 s, and 72 °C for 20 s, respectively,
and final extension at 72 °C for 4 min; the FastStart High Fidelity
PCR System, dNTPack (Roche) was used. The outer primers were used
for the first 30 cycles as described above with 20 μg mtDNA
template, followed by transfer of 2 μL of the first reaction
to the nested PCR for the second 30 cycles. Resulting products were
visualized by agarose gel electrophoresis.
Results
Label-Free
Proteomic Analysis for Development of a Mouse Brain
Mitochondrial Super-SILAC mix
To accurately quantify proteome
differences between synaptic and nonsynaptic mitochondria, we set
out to generate a super-SILAC mix that would be appropriate as a comprehensive
proteomic standard for mouse brain mitochondria. This is of particular
importance because variations in the mitochondrial proteome have been
observed among different cells, tissues, and disease states.[33−35] We chose the following mouse cell lines: the neuroblastoma derived
cell lines, Neuro-2a and NB41A3, the immortalized neuronal cell line,
CATH.a, and C8-D1A, a cell line with astrocytic properties. We first
performed label-free proteomic analysis of mitochondria isolated from
each cell line using sequential differential centrifugation and immunomagnetic
affinity purification (Figure 1A). Mitochondrial
protein lysate was trypsinized using the filter-aided sample preparation
(FASP) method[23] and subjected to MS using
a TTOF 5600 system (AB Sciex). Protein identification and spectral
counts were determined using ProteoIQ software. The protein spectral
counts, which are the total number of MS/MS spectra taken on peptides
from a given protein in a given LC–MS/MS analysis, were further
normalized by total spectral count. Using the Paragon algorithm,[25] 2396 proteins were identified from the mitochondria
from the four cell lines in total, which resulted in the identification
of more than 1200 proteins in each cell line (Figure 1B). The complete LC–MS/MS spectral count data for all
proteins identified using mitochondria isolated from each of the four
cell lines are provided in the Table S1A, Supporting
Information. A total of 842 proteins were identified in all
cell lines (35.1% of all identified proteins), and 39.6% protein identifications
were shared between at least two proteomes (Figure 1B). The complete list of the 842 common identified proteins
is provided in Table S1A, Supporting Information. To compare the proteomes of the cell lines to each other, we performed
hierarchical clustering of the 842 common proteins using normalized
spectral counts to reveal the degree of differences in protein expression
patterns at a global level. This revealed that CATH.a and C8-D1A show
the greatest dissimilarity (Figure 1C). Neuro-2a
and NB41A3, the two neuroblastoma derived cell lines, were found to
be the most similar (Figure 1C). To confirm
and expand the hierarchical clustering results, we performed principal
component analysis (PCA) of the spectral counts for all identified
proteins in all samples. PCA transforms large data sets into points
in a data space of orthogonal components, such that the first component
has the largest possible variance. This analysis confirmed that CATH.a
and C8-D1A were the furthest apart in this data space and supports
that our mixture of cell lines consists of diverse proteomes (Figure
S2A, Supporting Information). As a final
examination of the level of similarity of the protein expression patterns
between the different cell lines we calculated their Pearson correlation
coefficients (r), which further confirmed the highest similarity between
Neuro-2a and NB41A3 (Figure S2B, Supporting Information). Although the above analyses revealed that using a mixture of the
four cell lines indeed captures diversity important for proteomic
analysis, they do not provide evidence for mitochondrial proteome
enrichment.
Figure 1
Generation of a mouse brain mitochondrial super-SILAC mix. (A)
Label-free proteomics of isolated mitochondria from four mouse cell
lines was performed after FASP processing and LC-MS/MS on a TTOF 5600.
(B) Venn diagram of the common and unique proteins that were identified
and quantified from the isolated mitochondria from each of the four
cell lines. (C) Hiearchical clustering of the 842 common proteins
using normalized spectral counts. The values are displayed on a log10 scale.
Generation of a mouse brain mitochondrial super-SILAC mix. (A)
Label-free proteomics of isolated mitochondria from four mouse cell
lines was performed after FASP processing and LC-MS/MS on a TTOF 5600.
(B) Venn diagram of the common and unique proteins that were identified
and quantified from the isolated mitochondria from each of the four
cell lines. (C) Hiearchical clustering of the 842 common proteins
using normalized spectral counts. The values are displayed on a log10 scale.Therefore, we classified
the 2396 identified proteins with MitoMiner,
a database of the mitochondrial proteome, which annotated 1497 proteins
(62.5% of all identified proteins) as mitochondrial (Figure 2). The MitoMiner annotated proteins identified using
mitochondria from each of the four cell lines is provided in Table
S1B (Supporting Information). As shown
in Figure 2, unique mitochondrial proteins
were identified in each of the four cell lines (154 from C8-D1A, 79
from Neuro-2a, 75 from CATH.a, and 29 from NB41A3, which corresponds
to 10.3%, 5.3%, 5.0%, and 1.9% of all identified proteins, respectively),
further validating the use of this mix of four mitochondrial proteomes.
The MitoMiner annotated proteins identified as in common as well as
unique to mitochondria isolated from each of the four cell lines are
provided in Table S1B (Supporting Information). Although the enrichment of mitochondrial-localized proteins is
not 100%, it should be noted that proteins currently annotated as
nonmitochondrial may indeed be false negatives, as the ability to
localize proteins to mitochondria continues to increase.[36] The discrepancy can be explained due to the
fact that the functional annotation of proteins is incomplete and
constantly being updated. These results indicated that the use of
a mixture of isolated mitochondria from these four cell lines provides
enough similarity and diversity to adequately represent the mitochondrial
proteome.
Figure 2
MitoMiner annotated proteins. Venn diagram of the common and unique
proteins that were annotated to be mitochondrial by MitoMiner from
mitochondria isolated from each of the four cell lines.
MitoMiner annotated proteins. Venn diagram of the common and unique
proteins that were annotated to be mitochondrial by MitoMiner from
mitochondria isolated from each of the four cell lines.
Quantitative Analysis of Synaptic and Nonsynaptic
Mitochondrial
Proteomes Using the Mitochondrial Super-SILAC Mix
To examine
the differences in the synaptic and nonsynaptic mitochondrial proteomes,
two male 10-month-old (considered to be the beginning of adult middle
age in mice, approximating a 38-year old human[37]) littermate C57BL/6 mice were applied to our studies. First,
synaptic and nonsynaptic mitochondria were prepared from mouse brain
tissue using Percoll density gradient centrifugation to obtain “free”
nonsynaptic mitochondria and synaptosomes, and synaptic mitochondria
were released from synaptosomes by nitrogen cavitation as previously
described.[21] The purity of synaptic and
nonsynaptic mitochondria was determined using Western blot analysis
for the enrichment of mitochondrial markers and relative absence of
the soluble cytosolic protein GAPDH, as well as blotting for synaptophysin
to verify enrichment of synaptosomes (Figure S3A, Supporting Information). Transmission electron microscopy
using previously described ultrastructural criteria confirmed the
isolated synaptic and nonsynaptic mitochondria were pure and intact
(Figure S3B, Supporting Information).[38]Second, to create the mitochondrial super-SILAC
mix from the four selected cell lines we grew them in heavy (containing 13C615N4-l-arginine
and 13C6-l-lysine) SILAC media and
mixed the isolated mitochondrial lysates in equal proportions. The
heavy isotope-labeled cell line mitochondrial proteins were used as
internal standards to allow for comparison between unlabeled experimental
groups (synaptic and nonsynaptic mitochondria). Isolated synaptic
and nonsynaptic mitochondria were lysed and the proteins were mixed
in a 1:1 ratio with the mitochondrial super-SILAC mix prior to FASP,
12-Well OFFGEL fractionation, and acquisition of data on a TTOF 5600.
Joint analysis of the resulting 24 LC-MS/MS files (12 fractions for
both synaptic and nonsynaptic mitochondrial samples for each of the
two mice) in ProteinPilot using the Paragon algorithm identified a
total of 2260 common proteins in both the synaptic and nonsynaptic
mitochondria (Figure 3A). The complete super-SILAC
data for all proteins identified using synaptic and nonsynaptic mitochondria
isolated from mouse 1 and 2 as well as from the joint analysis are
provided in Table S1C (Supporting Information). Hierarchical clustering of the 2260 common proteins using the
normalized protein expression values (L/H) obtained using the heavy
super-SILAC mix as an internal standard for each of the mitochondrial
samples (synaptic and nonsynaptic) shows the global proteome differences
between synaptic and nonsynaptic mitochondria (Figure 3B). To evaluate the enrichment of mitochondria-localized proteins
within the synaptic and nonsynaptic mitochondrial proteomes, we uploaded
our list of 2260 common proteins to the MitoMiner database. The MitoMiner
database annotated 1869 proteins as mitochondrial, and of these, 1629
proteins are common to both synaptic and nonsynaptic mitochondria
(Figure 3C). The complete super-SILAC data
for all proteins identified as in common between synaptic and nonsynaptic
mitochondria isolated from mouse 1 and 2 as well as the joint analysis
including those annotated as mitochondrial using MitoMiner are provided
in Table S1D (Supporting Information).
Throughout the remainder of this paper, the term “mitochondrial
proteins” will refer only to the MitoMiner annotated mitochondrial
proteins. Although MS-based technical limitations may result in missing
low-abundance mitochondrial proteins and mitochondrial proteins expressed
only in specific tissues, developmental states, or cellular conditions
and may not be captured due to limitations of our super-SILAC mix
proteome coverage, we achieved 58.5% coverage of the mouse mitochondrial
proteome (2783 mitochondrial proteins currently annotated by the MitoCarta
Inventory of Mammalian Mitochondrial Genes). At this depth of proteome
coverage, we exceed current MS-based mitochondrial protein identification
as similar studies have only captured between 23 and 40% of known
mitochondrial components.[39]
Figure 3
Global proteomics results
obtained from super-SILAC experiment.
(A) Venn diagram of the common and unique proteins that were identified
and quantified from synaptic and nonsynaptic mitochondria. (B) Hierarchical
clustering of the expression levels of the 2260 common proteins. The
values are displayed on a log2 scale. (C) Venn diagram
of the common and unique proteins that were annotated to be mitochondrial
by MitoMiner from the synaptic and nonsynaptic mitochondria.
Global proteomics results
obtained from super-SILAC experiment.
(A) Venn diagram of the common and unique proteins that were identified
and quantified from synaptic and nonsynaptic mitochondria. (B) Hierarchical
clustering of the expression levels of the 2260 common proteins. The
values are displayed on a log2 scale. (C) Venn diagram
of the common and unique proteins that were annotated to be mitochondrial
by MitoMiner from the synaptic and nonsynaptic mitochondria.Although joint analysis identified
2260 proteins in common between
synaptic and nonsynaptic mitochondria, independent analysis of the
resulting 12 LC-MS/MS files for each of the two mice identified only
1720 and 1684 proteins in common between synaptic and nonsynaptic
mitochondria (Figure 4A and B). Of these proteins,
1619 were identified and quantified in both biological replicates
(Figure 4C), and 1278 were annotated as mitochondrial
using MitoMiner (Figure 4D). Reproducibility
is an important concern for quantitative proteomic studies. Therefore,
to confirm the reproducibility of the proteomic experiment, two independent
biological replicate preparations of proteins were performed for both
synaptic and nonsynaptic mitochondria. There was a high correlation
(the Pearson correlation coefficient r = 0.96 (synaptic)
and 0.94 (nonsynaptic)) between the two biological replicate samples
for both mitochondrial populations (Figure 5A,B). Additionally, the “ratio of ratio” distribution,
which is the change in protein expression between the two biological
replicates, resulted in curves generally composed of a normal distribution
centered at log2 0, consistent with normalized protein
abundance ratios, thus further correction was not performed (Figure 5C,D). The high correlation of protein expression
values between independent biological replicate samples indicated
that the use of the super-SILAC technique for quantitative proteomic
yields high reproducibility and accuracy, as reported previously.[18,19] These results also revealed that global proteomic differences exist
between synaptic and nonsynaptic mitochondria isolated from 10-month-old
mouse brain.
Figure 4
Comparison of identified synaptic and nonsynaptic mitochondrial
proteins. Venn diagram of the common and unique proteins that were
identified and quantified from synaptic and nonsynaptic mitochondria
isolated from (A) mouse 1 and (B) mouse 2. (C) Common and unique proteins
that were identified and quantified from synaptic and nonsynaptic
mitochondria from both mouse 1 and 2. (D) Common and unique proteins
that were annotated as mitochondrial by MitoMiner from synaptic and
nonsynaptic mitochondria from both mouse 1 and 2.
Figure 5
Experimental reproducibility and normalization. Scatter plot comparison
of the normalized protein expression values determined in one biological
replicate to another biological replicate analysis of proteins expressed
in (A) synaptic and (B) nonsynaptic mitochondria. Histogram of protein
ratios in one biological replicate versus another biological replicate
for (C) synaptic and (D) nonsynaptic mitochondria.
Comparison of identified synaptic and nonsynaptic mitochondrial
proteins. Venn diagram of the common and unique proteins that were
identified and quantified from synaptic and nonsynaptic mitochondria
isolated from (A) mouse 1 and (B) mouse 2. (C) Common and unique proteins
that were identified and quantified from synaptic and nonsynaptic
mitochondria from both mouse 1 and 2. (D) Common and unique proteins
that were annotated as mitochondrial by MitoMiner from synaptic and
nonsynaptic mitochondria from both mouse 1 and 2.Experimental reproducibility and normalization. Scatter plot comparison
of the normalized protein expression values determined in one biological
replicate to another biological replicate analysis of proteins expressed
in (A) synaptic and (B) nonsynaptic mitochondria. Histogram of protein
ratios in one biological replicate versus another biological replicate
for (C) synaptic and (D) nonsynaptic mitochondria.As with all quantitative MS-based experiments,
the prevalence of
missing data presents a challenge. Although missing values can be
replaced by an imputed value, determining reasonable imputed values
can be difficult in MS based shotgun proteomics experiments.[40,41] If the peptide intensity value is truly present at an abundance
the instrument should be able to detect it, but if it is not detected
or is incorrectly identified, then using observed values to impute
missing data or ignoring a few missing values is appropriate. However,
if a peptide intensity value is missing due to abundance below the
instrument’s detection limits or the peptide is not present,
then simple imputations based on observed values are not appropriate
as this will lead to biased results.[42] The
absence of peptide intensity values from one replicate sample does
not necessarily indicate that the peptide is not present or below
the detection limit; the value may be below the confidence limit set
for the analysis. Therefore, the joint analysis of the LC–MS/MS
files increases the number of spectra contributing to the quantitation
of the peptide thus raising the confidence in the protein to meet
the threshold set in ProteinPilot. We chose to address this situation
by joint analysis of the 24 LC–MS/MS files from each biological
replicate for each mitochondrial pool (synaptic or nonsynaptic) which
resulted in only 21, 29, 22, and 24 missing values for mouse 1 nonsynaptic,
mouse 2 nonsynaptic, mouse 1 synaptic, and mouse 2 synaptic mitochondria,
respectively. Lists of the proteins identified as unique due to missing
values in another sample are provided in Table S1E (Supporting Information).As mentioned above, if the
value was missing from both replicates
or from only one mitochondrial pool (synaptic or nonsynaptic), the
absence was assumed to be missing due to low abundance or absence
of the protein. In these cases, we chose to maintain the missing value
as missing, assuming there is a biological reason for the absence.
For this situation, we identified 212 proteins unique to nonsynaptic
mitochondria and 325 proteins unique to synaptic mitochondria (Table
S1E, Supporting Information). To determine
if these proteins unique to one mitochondrial pool are associated
with functions important for synaptic mitochondria we used the Database
for Annotation, Visualization, and Integrated Discovery (DAVID) functional
annotation tool for enrichment analysis and classified according to
the Gene Ontology (GO) term biological process and found that the
top five enriched biological processes were vesicle-mediated transport,
synaptic transmission, protein localization, cell–cell signaling,
and transmission of nerve impulse. In contrast, the top five enriched
biological processes using DAVID based on nonsynaptic unique proteins
were RNA processing, hexose metabolic process, cofactor metabolic
process, glucose metabolic process, and energy derivation by oxidation
of organic compounds.
Global Functional Assessment of Synaptic
and Nonsynaptic Mitochondrial
Proteins
In order to investigate the functional consequences
of these proteomic changes in synaptic compared to nonsynaptic mitochondria,
differentially expressed proteins were determined using the Bayesian
regularization method for high-throughput differential analysis[26] of the 1278 identified mitochondrial proteins
common between synaptic and nonsynaptic mitochondria (Figure 4D). The Posterior Probabilities of Differential
Expression (PPDEs) were derived and Benjamini and Hochberg corrections
were used. The resulting list of the 522 differentially expressed
proteins between synaptic and nonsynaptic mitochondria quantified
by super-SILAC are provided in Table S1F (Supporting
Information). The 522 differentially expressed proteins were
analyzed using the DAVID functional annotation tool for enrichment
analysis and classified according to the GO terms cellular component,
biological process, and molecular function. The GO analysis indicated
that the list of differentially expressed proteins was enriched for
mitochondrial proteins (Table 1). GO analysis
of the differentially expressed mitochondrial proteins showed enrichment
of biological processes related to generation of energy, metabolic
processes, and protein translation (Table 1). In addition, the enrichment of molecular functions related to
cofactor and nucleotide binding, inorganic cation transport, oxidoreductase
activity, and ribosome components were observed (Table 1). Although just outside the top 10 biological processes,
mitochondrion organization, which is of particular importance to mitochondrial
function was also enriched. To further investigate these functional
groups we used our proteomics data to investigate alterations in biological
pathways relevant to energy production, mitochondrion organization,
and transport of inorganic cations including oxidative phosphorylation
(OXPHOS), mitochondrial fission/fusion, and calcium transport.
Table 1
Gene Ontology (GO) Annotation for
Cellular Component, Biological Process, and Molecular Function Obtained
from the Database for Annotation, Visualization, and Integrated Discovery
(DAVID) for the 522 Accurately Quantified Differentially Expressed
Proteins (P Value ≤0.05, PPDE ≥ 0.95,
BH ≤ 0.05)
% enrichment
P value
GO: Cellular Component
1
mitochondrion
81.8
<8.5 × 10–226
2
mitochondrial part
47.8
8.5 × 10–226
3
mitochondrial envelope
31.1
2.6 × 10–127
4
mitochondrial membrane
30.3
7.6 × 10–127
5
mitochondrial inner membrane
27.8
5.4 × 10–126
6
organelle inner membrane
28.2
1.1 × 10–124
7
mitochondrial matrix
20.2
9.8 × 10–107
8
mitochondrial lumen
20.2
9.8 × 10–107
9
organelle envelope
31.9
4.9 × 10–106
10
envelope
31.9
9.5 × 10–106
GO: Biological Process
1
generation of precursor
metabolites and energy
17.7
5.5 × 10–76
2
oxidation reduction
22.8
2.0 × 10–62
3
electron transport chain
10.4
2.2 × 10–52
4
cellular respiration
5.8
1.3 × 10–29
5
oxidative phosphorylation
5.0
2.4 × 10–24
6
energy derivation by oxidation
of organic compounds
6.0
3.0 × 10–23
7
translation
9.6
1.3 × 10–22
8
cofactor metabolic process
6.9
1.2 × 10–19
9
coenzyme metabolic process
5.8
4.0 × 10–17
10
acetyl-CoA metabolic process
3.1
9.3 × 10–16
GO: Molecular Function
1
cofactor binding
9.4
7.1 × 10–28
2
monovalent inorganic cation
transmembrane transport
6.1
9.3 × 10–26
3
hydrogen ion transmembrane
transport
6.0
2.3 × 10–25
4
oxidoreductase activity,
acting on NADH or NADPH
5.0
3.3 × 10–25
5
coenzyme binding
7.5
4.3 × 10–24
6
oxidoreductase activity,
acting on NADH or NADPH, quinone, or similar compound as acceptor
3.6
7.4 × 10–22
7
NADH dehydrogenase (quinone)
activity
3.5
2.0 × 10–21
8
NADH dehydrogenase activity
3.5
2.0 × 10–21
9
NADH dehydrogenase (ubiquinone)
activity
3.5
2.0 × 10–21
10
inorganic cation transmembrane
transport
6.3
2.7 × 10–21
Decreased Expression of Electron-Transport
Chain Subunits in
Synaptic Compared to Nonsynaptic Mitochondria and Functional analysis
Since the analysis of the differentially regulated mitochondrial
proteins using GO revealed enrichment of proteins involved in generation
of energy pathways (Table 1), we further investigated
the differential expression between synaptic and nonsynaptic mitochondria
of the subunits of the protein complexes involved in the electron-transport
chain (ETC) and OXPHOS. Interestingly, all of the subunits of the
ETC that we identified, except for cytochrome c oxidase subunit IV
isoform 2 (COX4I2), exhibit reduced expression in synaptic compared
to nonsynaptic mitochondria (Figure 6A). Western
blot analysis was used to orthogonally validate the decrease in expression
of a subset of the ETC complex subunits (Figure 6B). The Western blot validation included at least one subunit from
each ETC complex and revealed that ATP synthase subunit alpha (ATP5A1),
cytochrome b-c1 complex subunit 2 (UQCRC2), cytochrome
c oxidase subunit 1 (MTCO1), succinate dehydrogenase iron–sulfur
subunit (SDHB), NADH dehydrogenase (ubiquinone) 1 β subcomplex
subunit 8 (NDUFB8), and ATP synthase subunit d (ATP5H) were lower
in synaptic versus nonsynaptic mitochondria consistent with our proteomics
findings.
Figure 6
Down-regulation of electron transport chain complex subunits. (A)
Heat map displaying the change in protein expression of mitochondrial
electron transport chain complex subunits in synaptic from nonsynaptic
mitochondria based on proteins quantified in the MS experiment. Proteins
highlighted in red were verified orthogonally. The values are displayed
on a log2 scale. (B) Western blot orthogonal validation
of protein expression for several electron-transport chain subunits.
VDAC1 is used as a loading control. (C) Seahorse XF24 electron flow
assay showing complex I, II, and IV driven oxygen consumption rate
(OCR) of synaptic and nonsynaptic mitochondria. Results are the mean
± SEM values (n = 6); synaptic (SYN) mitochondria
are significantly (**** = p < 0.0001) different
as compared with nonsynaptic (NS) mitochondria.
Down-regulation of electron transport chain complex subunits. (A)
Heat map displaying the change in protein expression of mitochondrial
electron transport chain complex subunits in synaptic from nonsynaptic
mitochondria based on proteins quantified in the MS experiment. Proteins
highlighted in red were verified orthogonally. The values are displayed
on a log2 scale. (B) Western blot orthogonal validation
of protein expression for several electron-transport chain subunits.
VDAC1 is used as a loading control. (C) Seahorse XF24 electron flow
assay showing complex I, II, and IV driven oxygen consumption rate
(OCR) of synaptic and nonsynaptic mitochondria. Results are the mean
± SEM values (n = 6); synaptic (SYN) mitochondria
are significantly (**** = p < 0.0001) different
as compared with nonsynaptic (NS) mitochondria.In order to investigate the functional outcome of the observed
proteomic changes, we used the Seahorse XF24 analyzer for sequential
measurement of oxygen consumption rate using the isolated synaptic
and nonsynaptic mitochondria.[30] In this
assay with pyruvate and malate acting as substrates oxygen consumption
by complex I is determined followed by inhibition with rotenone. Then
complex II activity, driven by succinate, is measured followed by
inhibition of complex III with antimycin A. Finally, ascorbate and
TMPD are used to drive complex IV respiration. As shown in Figure 6C, the synaptic mitochondria exhibit significantly
lower complex I, II, and IV driven respiration rates compared to nonsynaptic
mitochondria consistent with the proteomics results. In response to
stress (treatment with rotenone or antimycin A), both the synaptic
and nonsynaptic mitochondrial oxygen consumption rates were similarly
decreased (Figure S4, Supporting Information).
Differential Expression of Mitochondrial Fission/Fusion Proteins
As mentioned above, differentially expressed proteins were enriched
for the process of mitochondrial organization. Therefore, we evaluated
the expression of the proteins identified in our proteomic analysis
that are involved in mitochondrial fission/fusion. As seen in Figure 7A, proteins involved in mitochondrial fission/fusion
show differential expression in synaptic compared to nonsynaptic mitochondria.
Specifically, dynamin-1-like protein (DNM1L), which is the regulator
of mitochondrial fission, is increased (log2 = 0.54, p = 0.022, PPDE = 0.95, BH = 0.049) in synaptic compared
to nonsynaptic mitochondria. Although predominantly cytoplasmic, DNM1L
translocates to the mitochondria to mediate fission.[43] These results suggest a pro-fission state exists at the
synapse. Consistent with this finding, proteins involved in both inner
(dynamin-like 120 kDa protein; OPA1) and outer (mitofusin-1 and mitofusin-2;
MFN1 and MFN2, respectively) mitochondrial membrane fusion are all
reduced (OPA1: log2 = −0.74, p =
0.000, PPDE = 0.99, BH = 0.015) in synaptic compared to nonsynaptic
mitochondria. The decreased protein level of MFN1 in synaptic mitochondria
was validated orthogonally using Western blot analysis (Figure 7B).
Figure 7
Differential expression of proteins involved in mitochondrial
relevant
pathways including fission/fusion and calcium transport. Heat map
displaying the change in protein expression of (A) mitochondrial fission/fusion
and (C) calcium transport proteins in synaptic from those in nonsynaptic
mitochondria based on proteins quantitated in the MS experiment. Proteins
highlighted in red were verified orthogonally. The values are displayed
on a log2 scale. Western blot orthogonal validation of (B) MFN1 and
(D) MCU expression.
Differential expression of proteins involved in mitochondrial
relevant
pathways including fission/fusion and calcium transport. Heat map
displaying the change in protein expression of (A) mitochondrial fission/fusion
and (C) calcium transport proteins in synaptic from those in nonsynaptic
mitochondria based on proteins quantitated in the MS experiment. Proteins
highlighted in red were verified orthogonally. The values are displayed
on a log2 scale. Western blot orthogonal validation of (B) MFN1 and
(D) MCU expression.
Proteomic Implications
for Altered Calcium Transport in Synaptic
Mitochondria
The enrichment of proteins involved in the transport
of inorganic cations was revealed based on GO analysis of the differentially
expressed proteins in our proteomic analysis (Table 1). The homeostasis of calcium ions is specifically important
at neuronal synapses so we examined the differential expression of
proteins involved in calcium transport in synaptic compared to nonsynaptic
mitochondria. We observed alterations in the expression of proteins
important for calcium transport in our proteomics data (Figure 7C). Specifically, reduced expression of calcium
uniporter protein (MCU: log2 = −0.80, p = 0.001, PPDE = 0.99, BH = 0.015) and calcium uptake protein 1 (MICU1:
log2 = −0.89, p = 0.001, PPDE =
0.99, BH = 0.015) was found in synaptic mitochondria which is of particular
interest since these proteins regulate mitochondrial calcium handling
(Figure 7C).[44,45] Orthogonal
validation using Western blotting showed that MCU protein levels were
indeed lower in the synaptic compared to nonsynaptic mitochondria
(Figure 7D).
Alterations in Transcriptional
Regulation of Mitochondrial DNA-Encoded
Proteins
The observation that all of the identified mitochondrial
DNA (mtDNA) encoded ETC subunits showed decreased expression (Figure 6, Table 2) led us to examine
the mtDNA transcriptional machinery. Mitochondrial RNA polymerase
(POLRMT) and mitochondrial transcription factor A (TFAM) as well as
either mitochondrial dimethyladenosine transferase 1 (TFB1M) or mitochondrial
dimethyladenosine transferase 2 (TFB2M) are required for initiation
of mtDNA transcription.[46] Additionally,
the mitochondrial transcription termination factor (mTERF) facilitates
termination of mtDNA transcription.[46] Our
proteomics revealed that several proteins involved in mtDNA replication
and expression were decreased (POLRMT: log2 = −1.02, p = 0.020, PPDE = 0.95, BH = 0.046; SSBP1: log2 = −0.71, p = 0.021, PPDE = 0.95, BH = 0.048;
TFAM: log2 = −0.73, p = 0.004,
PPDE = 0.98, BH = 0.019) in synaptic compared to nonsynaptic mitochondria
(Figure 8A). The decreased protein expression
of TFAM was validated orthogonally via Western blotting (Figure 8B). Using IPA to investigate the TFAM transcriptional
regulation network overlaid with our expression data, we observe that
the downstream consequences of reduced TFAM levels are in line with
our proteomics data, TFAM inhibited proteins are decreased and TFAM
activated proteins are increased in synaptic mitochondria (Figure 8C). Since TFAM is responsible for transcriptional
control of mtDNA, the finding of decreased TFAM expression is consistent
with the observed reduced expression of mtDNA encoded proteins in
synaptic mitochondria.
Table 2
Mitochondrial DNA
Encoded Proteins
Quantified Using Super-SILAC Mix
log2 (synaptic/nonsynaptic)
protein names
gene names
replicate
avg
joint analysis
P value
PPDE
MTATP8
ATP synthase protein 8
–0.61
–0.56
5.6 × 10–3
0.98
MTCO1
cytochrome c oxidase subunit
1
–0.65
MTCO2
cytochrome c oxidase subunit
2
–0.65
–0.71
1.2 × 10–3
0.99
MTCYB
cytochrome b
–0.89
MTND1
NADH-ubiquinone oxidoreductase
chain 1
–0.75
–0.78
5.5 × 10–3
0.98
MTND4
NADH-ubiquinone oxidoreductase
chain 4
–0.68
–0.69
1.3 × 10–2
0.97
MTND5
NADH-ubiquinone oxidoreductase
chain 5
–0.60
–0.65
2.3 × 10–2
0.95
Figure 8
Mitochondrial DNA transcriptional regulation. (A) Heat map displaying
the change in protein expression of mtDNA transcriptional machinery
in synaptic from nonsynaptic mitochondria based on proteins quantified
in the MS experiment. Proteins highlighted in red were verified orthogonally.
The values are displayed on a log2 scale. (B) Western blot
orthogonal validation of TFAM protein expression. (C) TFAM transcriptional
regulator network from IPA.
Mitochondrial DNA transcriptional regulation. (A) Heat map displaying
the change in protein expression of mtDNA transcriptional machinery
in synaptic from nonsynaptic mitochondria based on proteins quantified
in the MS experiment. Proteins highlighted in red were verified orthogonally.
The values are displayed on a log2 scale. (B) Western blot
orthogonal validation of TFAM protein expression. (C) TFAM transcriptional
regulator network from IPA.
Synaptic Mitochondria Exhibit an Increased Presence of Mitochondrial
DNA Deletions
Multiple studies have shown age-dependent increases
in mtDNA deletions in several different tissues and in many different
species. Most mtDNA deletions are commonly found within regions flanked
by short direct repeats as seen in the Mus musculus mitochondrion complete genome map (Figure 9A).[32,47] Since synaptic mitochondria are believed
to be longer lived and to encounter more cellular stress, we chose
to examine the extent of mtDNA deletions in synaptic compared to nonsynaptic
mitochondria. PCR amplification of known age-associated mtDNA deletions
was performed as described previously.[32] We observed an increased presence of mtDNA deletions found within
the three-direct repeat region in synaptic compared to nonsynaptic
mitochondria (Figure 9B). These deletions resulted
in products of 989, 846, 753, 658, and 476 bp in length, which result
from the mtDNA breakpoints 9554/13278, 9088/12956, 9262/13224, 8992/13049,
and 8883/13120, respectively (Figure 9B). This
region of mtDNA contains coding sequence for five tRNAs (glycine (G),
arginine (R), histidine (H), serine (S), and leucine (L)) and five
ETC subunits (cytochrome c oxidase subunit 3 (COX3), NADH-ubiquinone
oxidoreductase chain 3 (ND3), NADH-ubiquinone oxidoreductase chain
4L (ND4L), NADH-ubiquinone oxidoreductase chain 4 (ND4), and NADH-ubiquinone
oxidoreductase chain 5 (ND5)). Therefore, increasing deletions within
this region may contribute to the overall decreased expression of
proteins encoded by mtDNA that we observed in synaptic as compared
to nonsynaptic mitochondria (Table 2).
Figure 9
Mitochondrial
DNA deletions. (A) Map of mouse mitochondrial DNA
showing tRNA (pink), rRNA, and protein coding (green) regions. Areas
prone to age-associated mutations are within the three-direct repeat
region. (B) PCR analysis of DNA isolated from synaptic and nonsynaptic
mitochondria revealing age-associated mitochondrial DNA deletions.
PCR of 12S rRNA is used as a control.
Mitochondrial
DNA deletions. (A) Map of mouse mitochondrial DNA
showing tRNA (pink), rRNA, and protein coding (green) regions. Areas
prone to age-associated mutations are within the three-direct repeat
region. (B) PCR analysis of DNA isolated from synaptic and nonsynaptic
mitochondria revealing age-associated mitochondrial DNA deletions.
PCR of 12S rRNA is used as a control.
Discussion
Mitochondrial functional and proteomic heterogeneity,
which seems
to be driven by the cellular environment, exists both between and
within cells and tissues.[34,48,49] In addition to displaying increased susceptibility to damage compared
to nonsynaptic mitochondria, studies have demonstrated that synaptic
mitochondria are more vulnerable to cellular insults such as Ca2+ overload[12] and oxidative stress.[50] Although several studies have characterized
the mouse brain synaptosomal proteome[51−53] and performed proteomic
analysis of mouse brain synaptic proteins,[54,55] the mitochondrial proteome differences between synaptic and nonsynaptic
mitochondria remain uncharacterized. In this study, we generated a
super-SILAC mix that served as an appropriate internal standard for
mouse brain mitochondria and performed a state of the art quantitative
proteomic characterization of the mousesynaptic and nonsynaptic mitochondrial
proteome at 10 months of age. This approach identified the differentially
expressed proteins between synaptic and nonsynaptic mitochondria pointing
to alterations in pathways important for function and integrity including
OXPHOS, mitochondrial fission/fusion, calcium transport, and mitochondrial
mtDNA replication and maintenance.Our label-free proteomic
analysis of mitochondria isolated from
each of the four cell lines derived from mouse neural and glial origin,
Neuro-2a, CATH.a, NB41A3, and C8-D1A, revealed that the use of a mixture
of mitochondria isolated from these four cell lines increased proteome
coverage and enabled representation of the mitochondrial proteome,
due to mitochondrial protein enrichment (Figure 1 and 2). The creation of a super-SILAC mix
from the four selected cell lines allowed for reproducible and accurate
quantification of the proteomic differences between synaptic and nonsynaptic
mitochondria isolated from 10-month-old mouse brains (Figures 3–5). In order to further
predict how these proteomic changes may be associated with mitochondrial
function and integrity, we used DAVID GO to determine the biological
processes and molecular functions that are enriched using our list
of 522 differentially regulated mitochondrial proteins. This analysis
revealed proteins enriched in several pathways were differentially
regulated between synaptic and nonsynaptic mitochondria (Table 1), specifically we chose to further investigate
those essential for synaptic mitochondrial function including OXPHOS,
mitochondrial fission/fusion, and calcium transport.In particular,
the synapse relies on high ATP production for vesicle
mobilization and maintenance of membrane potential.[56] Therefore, we evaluated the proteomic changes associated
with mitochondrial energy generation, the OXPHOS machinery. All of
the subunits of the ETC that we identified, except for COX4I2, exhibited
reduced expression in synaptic compared to nonsynaptic mitochondria
which correlated with decreased complex I, II, and IV driven respiration
(Figure 6). Given the demand for ATP at the
synapse, this decrease in ETC complex subunits may be compensated
for by trafficking of mitochondria resulting in a high density of
mitochondria at the synapse.[4,57] Furthermore, decreases
in mitochondrial ETC complex activities have been implicated in neurodegenerative
diseases and aging, and our data provide evidence that the reduced
activity may be a result of further proteomic alterations, as the
reduced levels of the ETC complex subunits may make synaptic mitochondria
more sensitive to such changes. In fact, synaptic mitochondria have
been shown to exhibit more drastic reductions in rates of respiration
and ATP production upon complex I inhibition compared to nonsynaptic
mitochondria which was attributed to lower complex I activity in synaptic
mitochondria.[58] Our data suggest that proteomic
differences between synaptic and nonsynaptic mitochondria might explain
these earlier findings, in that reduced expression of complex I subunits
may contribute to the energy threshold whereby inhibition of mitochondrial
OXPHOS would compromise energy homeostasis in the synapse and not
near the neuronal soma.Mitochondrial fission/fusion cycles
are essential for the maintenance
of mitochondrial integrity.[59] The observed
alterations in the key proteins involved in regulating mitochondrial
fission (increased DNM1L) and fusion (decreased OPA1, MFN1, and MFN2)
suggest decreased fusion and the presence of increased fragmentation
in the synaptic mitochondrial pool, which has been shown to result
in decreased ATP production (Figure 7).[60] However, DNM1L not only controls fission but
also mitochondrial localization to synapses regulating neuronal signaling.[61] Therefore, these proteomic alterations suggest
that synaptic mitochondria may exhibit changes in morphology that
could impact their function and integrity. However, further work is
necessary to validate the functional consequences of DNM1L expression
changes on mitochondrial morphology and localization. In fact, altered
mitochondrial dynamics are implicated to contribute to the pathology
of many neurodegenerative disorders including Parkinson’s,
Alzheimer’s, and Huntington’s diseases.[62,63]In addition to producing ATP, mitochondria are necessary for
maintaining
proper calcium homeostasis at the neuronal synapse.[61] Interestingly, synaptic mitochondria display increased
susceptibility to calcium-induced dysfunction and calcium overload
compared to nonsynaptic mitochondria.[12,16] Mitochondrial
calcium uptake is mediated by a calcium-selective ion channel,[45] and the pore-forming subunit MCU was recently
shown to interact with MICU1, which was shown to be essential to prevent
mitochondrial calcium overload.[44] Our proteomics
revealed that the expression of both MCU and MICU1 is decreased in
synaptic compared to nonsynaptic mitochondria (Figure 7). Interestingly, synaptic activity has been shown to transcriptionally
repress MCU which prevents excitotoxic death.[64] Therefore, although reduced MCU expression (as observed by our proteomics)
would be expected to be beneficial for survival, this may also leave
the synaptic mitochondria more susceptible to calcium overload.Based on our proteomic expression data, all of the ETC complex
subunits encoded by mtDNA show reduced expression in synaptic compared
to nonsynaptic mitochondria (Figure 6; Table 2). Consistent with this finding, the mtDNA transcriptional
machinery including TFAM, the master regulator of transcription for
the mitochondrial genome, was reduced in synaptic compared to nonsynaptic
mitochondria (Figure 8). The IPA upstream regulators
tool revealed that decreased levels of TFAM were also consistent with
the observed protein expression levels of other downstream targets
(Figure 8). In addition to mtDNA transcription,
TFAM is also recruited to mitochondria for mtDNA maintenance and biogenesis.[65] Therefore, decreased levels of TFAM may contribute
to synaptic mitochondrial increased sensitivity to damage and reduced
integrity.Since synaptic mitochondria have been shown to be
especially vulnerable
to cumulative age-associated damage,[13] we
investigated the presence of mtDNA damage. Our finding of increased
synaptic mitochondrial mtDNA deletions compared to nonsynaptic mitochondria
supports other findings that synaptic mitochondria are more vulnerable
to age-related damage (oxidative or otherwise) (Figure 9). Interestingly, recent studies have revealed that most mtDNA
mutations in aged cells appear to be caused by early replication errors
which propagate with time;[66] thus, this
finding also supports the idea that synaptic mitochondria are longer
lived than nonsynaptic.
Conclusions
Here we have characterized
the differences between synaptic and
nonsynaptic mitochondria using a quantitative proteomics approach.
Our work indicates that global proteomic differences exist between
synaptic and nonsynaptic mitochondria. Synaptic mitochondria exhibit
distinct protein expression indicative of decreased energy generation,
as well as altered mitochondrial morphology and calcium transport
compared to their nonsynaptic counterparts. Our findings suggest changes
in the mitochondrial proteome could explain the observed vulnerability
of synaptic mitochondria to inhibitors of ETC complexes, calcium,
as well as age-associated damage. We identified an increase in the
presence of mtDNA damage coinciding with decreased TFAM levels in
synaptic compared to nonsynaptic mitochondria. We hypothesize that
some of the same proteomic alterations that allow synaptic mitochondria
to provide for the unique demands of synapses may also lead to synaptic
mitochondrial vulnerability. This study provides the basis for further
experiments on the role of synaptic mitochondrial proteins in neurodegenerative
disorders as well as normal aging.
Authors: Jonathan Lifshitz; Hans Friberg; Robert W Neumar; Ramesh Raghupathi; Frank A Welsh; Paul Janmey; Kathryn E Saatman; Tadeusz Wieloch; M Sean Grady; Tracy K McIntosh Journal: J Cereb Blood Flow Metab Date: 2003-02 Impact factor: 6.200
Authors: Kelly L Stauch; Lance M Villeneuve; Steven Totusek; Benjamin Lamberty; Pawel Ciborowski; Howard S Fox Journal: Dev Neurobiol Date: 2019-05-09 Impact factor: 3.964
Authors: Zuzana Tatarkova; Maria Kovalska; Veronika Timkova; Peter Racay; Jan Lehotsky; Peter Kaplan Journal: Neurochem Res Date: 2016-05-09 Impact factor: 3.996
Authors: Kelly L Stauch; Lance M Villeneuve; Phillip R Purnell; Brendan M Ottemann; Katy Emanuel; Howard S Fox Journal: Proteomics Clin Appl Date: 2016-09-21 Impact factor: 3.494